Clinical Trial Update: Open-Label Study of Safety of H1337 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Open-label Phase 1 safety study of H1337 in healthy volunteers completed; Open-angle glaucoma and ocular hypertension are listed as the study conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• H1337

Snippet

Sponsor: D. Western Therapeutics Institute, Inc. | Conditions: Glaucoma Open-Angle Primary, Ocular Hypertension | Phase 1 | Status: COMPLETED